image

image

image

image

image

image

Today (April 29), good news from the UAE! Sinopharm China Bio-Beijing Institute of Biological Products and Wuhan Institute of Biological Products, two inactivated vaccines of Omicron variant (hereinafter referred to as "Australis", Sinopharm Zhongsheng Biotechnology Research Institute/National Engineering Research Center for New Vaccines ( The recombinant new crown vaccine developed by the Chinese Academy of Biological Research), a total of three Austrian strains of the new crown vaccine, have been approved for clinical trials by the Ministry of Health in Abu Dhabi, United Arab Emirates. This is an important progress in the global multi-center clinical trial of China Bio-Aostrain COVID-19 vaccine.

image

image